With over 20 years of experience in data science and biostatistics, she is the former Chief Technology Officer and Co-Founder of Novigenix, a company focused on developing innovative liquid biopsy solutions for cancer detection and monitoring. At Novigenix, she led the data strategy, built the AI platform, and guided the clinical validation of products.
She holds a PhD in Statistics and Machine Learning from EPFL, complemented by executive education programs at IMD and MIT, along with a PMP® certification from the Project Management Institute. This strong academic background supports her leadership roles.
An entrepreneur at heart, she is passionate about creating impactful, scalable solutions that leverage data and technology to advance precision oncology.
Currently, she serves as Chief Quality Officer at Prevision Medicine, a spin-off from ETH Zurich, where she leads the regulatory strategy and commercialization of their data-driven technology to improve patient outcomes. She also supports Xempera, a company specializing in Xadvanced cancer diagnostic technologies.
You can learn more about Sahar by visiting her LinkedIn profile